Fundraising Fox
Magnetic Ventures
Venture capitalActively deployingBoston · Seed–Series A · 9 people tracked
Find your way into Magnetic Ventures
Sign up to see every warm intro you have to Magnetic Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Magnetic Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Magnetic Ventures invests in companies at the intersection of deep tech and life sciences, focusing on software tools, artificial intelligence, machine learning, multi-omics, drug discovery, precision medicine, and tech-enabled services. The firm seeks exceptional science and founders fluent across biology, chemistry, software, hardware, ML, and AI, with a team bringing technical expertise in engineering, biology, genomics, and biotechnology. Drawing on decades of industry experience spanning FDA meetings, business development, and scaling technologies including PCR, the firm navigates the full healthcare lifecycle from discovery through regulatory approval to commercialization. It typically enters at seed or Series A, aiming to support founders early and throughout the company lifecycle.
Source: firm website, verified Oct 24, 2026.
Team · 9 people
from the firm's website & public directories)
Christine Aylward is the founder and managing partner of Magnetic Ventures, an early-stage venture capital firm focused on deep tech and life sciences investments. She previously held executive positions at Roche and Sanofi, and has experience building startups.
)
)
)
What they invest in
from 20 of 28 portfolio companiesBiotech ×13AI & Machine Learning ×11Healthtech ×9Digital Health ×7Deep Tech ×6Medical Devices ×4Enterprise Software ×2Impact & Social Good ×2
HQs:United States×16Canada×1
Who they back
founder profiles across 12 portfolio companiesFounding team size:solo founder×52 founders×33 founders×34+ founders×1
Where their founders studiedfrom 16 founders with education data
Stanford University School of Medicine ×2University of Arizona ×2
What their founders studiedfrom 15 founders with field-of-study data
Life Sciences ×7Chemistry ×3Computer Science ×3Business & Management ×2Engineering ×2
Where their founders worked beforefrom 16 founders with career history
Columbia University in the City of New York ×3Gilgamesh Pharma ×2McKinsey & Company ×2Roivant ×2
Investments · 28 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 32023 · 22022 · 22021 · 22020 · 214 dated
Amydis develops proprietary ocular tracers that detect molecular biomarkers for diseases of the eye, heart, and brain through non-invasive eye-based testing.
BiotechDigital HealthMedical DevicesLos Angeles, US
Stella Sarraf(Executive Officer, Director)inJames Khodabakhsh(Director)Mervyn Turner(Director)Faith Charles(Director)
Board seatChristine Aylward· per SEC Form D · $6M raise · filed Dec 2023
Relation RX is a biotech company focused on discovering novel medicines through an interdisciplinary approach combining expertise from technology, pharma, academia, and venture.
AI & Machine LearningBiotechDeep TechMiami Beach, US
David Roblin(Chief Executive Officer)inCasey Benjamin Swerner(Executive Officer)inBenjamin Swerner(Founder)Charles Roberts(Founder)Jake Taylor-King(Founder)
BoardJason Pontin(Director)
Board seatChristine Aylward· per SEC Form D
Co-investorsDCVC (Data Collective)Hitachi VenturesRaptor GroupDeerfield Management CompanyKhosla VenturesNVentures
AppliedVR develops immersive therapeutic software using technology to deliver drug-free clinical treatments for patients.
Digital HealthHealthtechMedical DevicesLos Angeles, US
Matthew Stoudt(Co-Founder and CEO)inJosh Sackman(Co-Founder and President)in
BoardDavid Sackman(Chairman)
Co-investorsEntrada VenturesF-Prime CapitalJAZZ Venture PartnersPresence CapitalTechstarsGSR Ventures+1 more
Deep Genomics develops AI-based biological foundation models to identify drug targets and design molecules, aiming to speed up drug discovery.
AI & Machine LearningBiotechDeep TechToronto, CA
Brendan Frey(Founder)inBrian O'Callaghan(Chief Executive Officer)inDavid Johnston(Chief Financial Officer)inClive Bertram(Chief Business Officer)inTom Masterson(Chief Operating Officer)inGreg Hoffman(Chief Scientific Officer)in
Co-investors11.2 CapitalBloomberg BetaFuture VenturesKensington Capital Partners LimitedSoftBank Vision FundTrue Ventures+2 more
Eclipsebio provides RNA biology analytical services and sequencing-based assays that help drug developers and researchers characterize RNA at nucleotide-level resolution and generate datasets for AI-driven drug discovery.
AI & Machine LearningBiotechDeep TechSan Diego, US
Eugene Yeo(Director)Peter Chu(Executive Officer, Director)inEric L Van Nostrand(Director)Hallie Kuhn(Director)
BoardEdmond Wong(Director)inDaniel Vasella(Director)
Co-investorsBrainstorm VenturesiGlobe PartnersPhoenix Venture Partners
Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.
AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US
Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Thomas Kevin Murphy, Ph.D.(Executive Officer)JONATHAN SPORN(Founder)in
Co-investorsAera VCAlumni VenturesAwareness VentureFrontera Technology VenturesFrontier Path VCGaingels+27 more
__Twitter.png)
GroundGame.Health operates a technology platform and hyperlocal operating model that connects health plans, providers, employers, and community-based organizations to address barriers to care and social determinants of health.
Digital HealthHealthtechImpact & Social GoodSocialTampa, US
Susan Rawlings Molina(Executive Officer, Director, Promoter)inSridhar Akula(Executive Officer, Director)Aimee Dailey(Director)
BoardRobert Garber(Director)inShantanu Agrawal(Director)Jennifer Jarrell(Director)
Co-investors7wire VenturesCorewell Health VenturesFalconX VenturesRaptor Group
HiberCell develops therapeutic candidates targeting the Integrated Stress Response pathway to address treatment-resistant cancers, relapse, and metastasis.
BiotechMedical Devices
Julio Aguirre-Ghiso, Ph.D.(Co-Founder)Steven Gillis, Ph.D.(Chairman & Acting CEO)
Co-investorsARCH Venture PartnersRaptor Group6 Dimensions CapitalHercules Capital, Inc.Hillhouse Capital
Luminal provides AI model compilation and inference optimization software that compiles models into optimized native code for GPUs and ASICs, delivering 2-3x faster inference performance compared to traditional runtime inference engines.
AI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareSan Francisco, US
Joe Fioti(CEO)inMatthew Gunton(CTO)inJake Stevens(Founder)inJacob Stevens(Executive Officer, Director)
Co-investorsFelicis VenturesSaga VenturesSpot VCSterling RoadY CombinatorA.Capital Ventures+19 more
Paradigm Health provides technology and services that integrate with healthcare provider organizations to improve the clinical trial process.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSaaSColumbus, US
Kent Thoelke(Founder)inJonathan Hirsch(Chief Strategy and Growth Officer)Jay Trepanier(Chief Financial Officer)inElijah Meerson(Chief Technology Officer)inMichelle Lee(Chief Operating Officer)in
Co-investorsARCH Venture PartnersGeneral CatalystGV (Google Ventures)Lux CapitalF-Prime CapitalJobsOhio Ventures+2 more
.png)
Prompt is an Ambient AI product and research company that develops human-centered AI products designed to sense the physical environment.
AI & Machine LearningConsumerDeep TechSan Francisco, US
Tete Xiao(Founder)in
Co-investorsAbstract VenturesAIX VenturesDCVC (Data Collective)Neotribe VenturesAlexandriaBraidwell+4 more
Proxima is a biotech company developing proximity therapeutics through a drug discovery engine and a structural proteomics data platform.
AI & Machine LearningBiotechDeep Tech
Jonathan Bernardini(Founder)inZachary Carpenter(Co-Founder & CEO)inLuca Naef(Co-Founder & CTO)in
Co-investorsModi VenturesDCVC (Data Collective)
Proxima develops AI-powered gaming experiences and infrastructure, with a focus on embodied AI agents and applied AI systems for interactive entertainment.
AI & Machine LearningGamingSan Francisco, US
Ran Mo(Founder)in
Co-investorsAIX VenturesKonvoy VenturesProgressionAlexandriaBalderton CapitalBayern Kapital+9 more
Resilience is a contract development and manufacturing organization (CDMO) that manufactures complex pharmaceutical products and active pharmaceutical ingredients to broaden access to medicines and protect biopharmaceutical supply chains against disruption.
Advanced ManufacturingBiotechEnterprise SoftwareBlue Ash, US
William S. Marth(Chief Executive Officer)William S. Marth, RPh., MBA(President & CEO)
BoardRobert Nelsen(Chairman, Resilience; Founder, ARCH)
Co-investors8VCARCH Venture PartnersCatalio Capital Management, LPGlobal Health Investment CorporationGV (Google Ventures)Koch Disruptive Technologies+14 more
GroundGame.Health connects health plans, providers, employers, and community-based organizations with care coordinators who address social needs and barriers to care through local, culturally tailored human interactions.
Digital HealthHealthtechImpact & Social Good
Co-investors7wire VenturesCorewell Health VenturesRaptor Group
HealthtechSan Francisco, US
ALEXANDER MARSON(Executive Officer, Director)PATRICK DAVID HSU(Director)JACOB CORN(Director)
BoardBLAKE BYERS(Director)in
Co-investorsTeam Builder VenturesGV (Google Ventures)
Stipple Bio develops targeted oncology therapies that act on tumor-specific cell surface epitopes to expand druggable targets and improve therapeutic index for cancer patients.
BiotechHealthtechCambridge, US
Aaron Ring(Co-founder)inAashish Manglik(Co-founder)inJeff Landau(Chief Executive Officer)inRoland Gendron(Chief Business Officer)inMichelle Zhang(Chief Scientific Officer)in
BoardVineeta Agarwala(Director)in
Co-investorsRA CapitalAndreessen HorowitzGV (Google Ventures)OMX VenturesAxial VCLoLa Capital Partners+1 more
Tools company creating key components for next generation treatments
Co-investorsBrainstorm VenturesHAWKTAILTranspose Platform ManagementEx Nihilo
Transition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease.
AI & Machine LearningBiotechDeep TechCambridge, US
Tuomas Knowles(Executive Director, Co-Founder & Chief Technology Officer)Samuel Cohen(Executive Director & Co-Founder)inG. Kelly Martin(Executive Chairman & Co-Founder)George Martin(Executive Officer, Director)inStephanie Torruella(Executive Officer)inPreet Makkar(Executive Officer)
Co-investorsNorthpond VenturesLifeforce CapitalTaiho Ventures, LLCDolby Family Ventures
Triveni Bio develops genetics-informed antibody therapeutics aimed at treating complex immunology and inflammation (I&I) diseases.
BiotechDigital HealthHealthtech
Vishal Patelin
Co-investorsAscenta CapitalAtlas VentureBorealis VenturesBorealis VenturesOrbiMedViking Global+4 more
Weave Bio builds AI-assisted software for regulatory teams in drug development to author, organize, and manage eCTD submission content across the regulatory lifecycle, covering documents from investigator's brochures and clinical study reports through IND, NDA, and BLA development.
AI & Machine LearningBiotechHealthtechSaaSSan Francisco, US
Ari Caroline(Chief Strategy Officer)inBrandon Rice(Chief Executive Officer)in
Co-investorsFirsthandVCGround Up VenturesRaptor GroupTMVUS Venture PartnersCharacter+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Weave Platform, Inc.EclipsebioEmmeGilgameshSameSky HealthStippleTriveni Bio
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 3
3 acquisitions · showing 2Gilgamesh Pharmaceuticalsacq. by AbbVieSameskyacq. by GroundGame.Health
Portfolio news
latest coverage across their companiesTriveni · finsmes.com · Jun 17, 2026
Gilgamesh Pharmaceuticals · nasdaqprivatemarket.com · Apr 3, 2026
Proxima · finance.yahoo.com · Jan 13, 2026
Paradigm Health · finsmes.com · Dec 4, 2025
Luminal · finsmes.com · Nov 20, 2025
Weave Bio · finsmes.com · Oct 17, 2025
Frequently asked questions
- How many investments has Magnetic Ventures made?
- Magnetic Ventures has 28 tracked investments, 3 of which have exited, including 6 dated in the last 24 months.
- What stage does Magnetic Ventures invest at?
- Magnetic Ventures invests at the Seed, Series A stages.
- What is Magnetic Ventures's typical check size?
- Magnetic Ventures typically writes checks of $1M – $6M.
- What sectors does Magnetic Ventures focus on?
- Magnetic Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Magnetic Ventures located?
- Magnetic Ventures is headquartered in Boston, US.
- Does Magnetic Ventures lead rounds?
- Yes, Magnetic Ventures leads investment rounds.
- Who does Magnetic Ventures co-invest with?
- Magnetic Ventures most often shares deals with Raptor Group, ARCH Venture Partners, GV (Google Ventures), among 67 tracked co-investors.
Media · Podcasts & interviews
featuring the teamFrom PCR to Portfolio: Christine Aylward is Funding Life Sciences
Get Real with Jim Weiss · Christine Aylward
Co-investors · 10
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Innovation Endeavors is an early-stage venture fund that invests in founders and supports venture creation through pre-team and pre-idea programs. The firm provides portfolio companies with access to mentors, advisors, and an entrepreneur ecosystem.
CRV is a venture capital firm that backs founders at the seed and Series A stages, focusing on those with deep conviction and unique insights.
Inovia Capital is a full-stack venture capital firm based in Canada with a presence in the EU, partnering with founders to build global technology companies.
Practical Venture Capital (PVC) is a Silicon Valley firm specializing in the venture capital secondary market, acquiring LP and GP interests in venture funds and direct secondary stakes in late-stage private companies. Its 'Skip the J-Curve' strategy targets proven winners at a discount with liquidity in 3-5 years.
LOI Venture is a seed-stage venture fund co-founded by Hootsuite Founder Ryan Holmes and Angel Investor Manny Padda focused on backing founders under 30 usually building tech products attending the LOI Program.
Golden Ventures is an early-stage venture capital firm focused on seed-stage technology companies, with over 100 investments to date.
Structure Capital is a seed-stage venture capital firm that provides funding and support to early-stage companies. The firm offers capital, mentorship, and network access to portfolio companies.
Highline Beta is a venture studio and pre-seed venture capital firm that partners with corporations and family offices to build and fund new ventures beyond their core business.
Deeptech Labs is an accelerator and venture capital fund based in Cambridge that invests in deep technology companies. The firm leverages resources from Cambridge's academic and commercial sectors.
Firms observed investing alongside Magnetic Ventures, from public investor directories. Shared companies are the overlap with Magnetic Ventures's recorded portfolio.
Similar investors
Future Positive Capital is a venture firm that backs entrepreneurs building companies aimed at solving universal challenges at planetary scale across science and technology.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
ARTIS Ventures is a venture capital firm investing in breakthrough companies at the convergence of technology and biology, with a focus on healthcare and life sciences ('TechBio'). It backs founders across biotech, therapeutics, digital health, and frontier technologies.
JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.